A5056411903- Nerve injury and regeneration
- Suicide and Self-Harm Studies
- Autism Spectrum Disorder Research
- Obsessive-Compulsive Spectrum Disorders
- Mental Health Treatment and Access
- Tryptophan and brain disorders
- Psychosomatic Disorders and Their Treatments
- Pharmacological Receptor Mechanisms and Effects
- Religion, Spirituality, and Psychology
- Long-Term Effects of COVID-19
- COVID-19 and Mental Health
- Electrolyte and hormonal disorders
- Neurological Disorders and Treatments
- Terrorism, Counterterrorism, and Political Violence
- Cultural Differences and Values
- Pain Management and Treatment
- Pharmacogenetics and Drug Metabolism
- Workaholism, burnout, and well-being
- Transcranial Magnetic Stimulation Studies
- Bipolar Disorder and Treatment
- Neurotransmitter Receptor Influence on Behavior
- Migraine and Headache Studies
- Neurogenesis and neuroplasticity mechanisms
- Pharmaceutical studies and practices
- Circadian rhythm and melatonin
University of Cagliari
2022-2025
Khazar University
2018-2025
Abstract Background and aims Despite the last decade's significant development in scientific study of work addiction/workaholism, this area research is still facing a fundamental challenge, namely need for valid reliable measurement tool that shows cross-cultural invariance and, as such, allows worldwide studies on phenomenon. Methods An initial 16-item questionnaire, developed within an addiction framework, was administered alongside job stress, satisfaction, self-esteem measures total...
Treatment-resistant depression (TRD) affects approximately 30% of patients with major depressive disorder (MDD), for whom effective treatment options are limited. Repetitive transcranial magnetic stimulation (rTMS) has shown efficacy in alleviating symptoms TRD. However, it remains unclear if these improvements driven or mediated by changes cognitive function biological markers, such as brain-derived neurotrophic factor (BDNF). This study examines the effects rTMS on symptoms, cognition, and...
Brain-derived neurotrophic factor (BDNF) is a key modulator of neuroplasticity and has an important role in determining the susceptibility to severe psychiatric disorder with significant neurodevelopmental component such as major psychoses. Indeed, potential association between BDNF serum levels schizophrenia (SCZ) schizoaffective (SAD) been tested diverse studies considerable amount them found reduced these disorders. Here, we aimed at testing several demographic, clinical, psychometric...
Schizophrenia spectrum disorders are among the most debilitating mental and has complex pathophysiological underpinnings. There is growing evidence that brain-derived neurotrophic factor (BDNF) can play a role in its pathogenesis. The present study investigated longitudinal variation of serum BDNF levels 24-month observational prospective cohort Sardinian psychotic patients relationship with psychopathological cognitive changes. Furthermore, we examined whether genetic within gene could...
Schizophrenia (SCZ) and schizoaffective disorder (SAD) are severe complex psychiatric disorders whose liability threshold is modulated by the interplay of biological, mainly genetic, environmental factors. Consistent evidence has pointed to role serum brain‐derived neurotrophic factor (BDNF) as a plausible illness biomarker in SCZ spectrum disorders. There no consensus, however, on temporal trajectory this decline. Here, we present secondary analysis Longitudinal Assessment BDNF Sardinian...
Identifying phenotypes at high risk of suicidal behaviour is a relevant objective clinical and translational research can facilitate the identification possible candidate biomarkers. We probed potential association eventual stability neuropsychological profiles serum BDNF concentrations with lifetime suicide ideation attempts (LSI LSA, respectively) in individuals schizophrenia (SCZ) schizoaffective disorder (SCA) 2-year follow-up study. A secondary analysis was conducted on convenience...
Introduction Psychotic disorders present a significant lifetime risk for suicide. Past estimates suggest that up to 25-50% of individuals with schizophrenia (SCZ) may attempt suicide during their lifetime. A growing body literature indicates the level cognitive performances be associated differing attempts, albeit inconsistently depending on diagnostic category and study setting. However, vast majority in field is composed cross-sectional studies, limiting overall interpretation available...
Introduction Schizophrenia spectrum disorders are among the most debilitating mental and evidence on its pathophysiological underpinnings is scant. The brain-derived neurotrophic factor (BDNF) appears to be involved in pathophysiology of these complex psychiatric disorders. Objectives present study investigates longitudinal variation serum BDNF levels a 24-month observational cohort Sardinian psychotic patients (LABSP). This assessed relationship with psychopathological cognitive changes....